ImmunityBio (IBRX) Retained Earnings (2013 - 2026)
ImmunityBio (IBRX) reported Retained Earnings of -$4.4 billion for Q1 2026, down 25.54% year-over-year from -$5.9 billion in Q1 2025, and down 15295.47% quarter-over-quarter from $29.0 million in Q4 2025.
ImmunityBio (IBRX) Retained Earnings (2013 - 2026) Analysis & Trends
ImmunityBio (IBRX) has 14 years of Retained Earnings data on file, last reported at -$4.4 billion in Q1 2026.
- Retained Earnings for Q1 2026 came in at -$4.4 billion, down 25.54% year-over-year; the trailing twelve-month figure through Mar 2026 was -$4.4 billion (down 25.54% YoY), and the FY2025 annual result was $29.0 million, up 2317.03% from the prior year.
- Retained Earnings declined to -$4.4 billion in Q1 2026 per IBRX's latest filing, from $29.0 million in the prior quarter.
- Over five years, Retained Earnings peaked at $29.0 million in Q4 2025 and troughed at -$4.4 billion in Q1 2026.
- A 5-year average of -$1.8 billion and a median of -$2.5 billion in 2023 frame the typical range for Retained Earnings.
- On a YoY basis, Retained Earnings climbed as much as 2317.03% in 2025 and fell as far as 50069814.29% in 2025.
- A 5-year view of Retained Earnings shows it stood at $183000.0 in 2022, then plunged by 1618506.56% to -$3.0 billion in 2023, then surged by 100.04% to $1.2 million in 2024, then soared by 2317.03% to $29.0 million in 2025, then slumped by 15295.47% to -$4.4 billion in 2026.
- Business Quant data shows IBRX's Retained Earnings at -$4.4 billion in Q1 2026, $29.0 million in Q4 2025, and -$3.7 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | ImmunityBio | 7.55 Bn | 7.17 Bn | 43.97 Mn | -4.40 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.40 Bn |
| Dec 31, 2025 | 28.96 Mn |
| Sep 30, 2025 | -3.66 Bn |
| Jun 30, 2025 | 12.57 Mn |
| Mar 31, 2025 | -3.50 Bn |
| Dec 31, 2024 | 1.20 Mn |
| Sep 30, 2024 | -3.32 Bn |
| Jun 30, 2024 | -3.23 Bn |
| Mar 31, 2024 | -7,000.00 |
| Dec 31, 2023 | -2.96 Bn |
| Sep 30, 2023 | -2.73 Bn |
| Jun 30, 2023 | -2.60 Bn |
| Mar 31, 2023 | -2.50 Bn |
| Dec 31, 2022 | 183,000.00 |
| Sep 30, 2022 | -190,000.00 |
| Jun 30, 2022 | -2.20 Bn |
| Mar 31, 2022 | -367,000.00 |
| Dec 31, 2021 | -1.96 Bn |
| Sep 30, 2021 | -1.87 Bn |
| Jun 30, 2021 | 37,000.00 |